NCT01163825 Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients Status UNKNOWN Phase PHASE1
NCT01148498 A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's Status COMPLETED Phase PHASE2
NCT01147679 Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls Status UNKNOWN Phase N/A
NCT01143350 Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders Status TERMINATED Phase NA
NCT01137799 The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients Status TERMINATED Phase PHASE1
NCT01137526 Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01133405 A Safety Study of LY2886721 Single Doses in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01129596 Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease- Status COMPLETED Phase N/A
NCT01129115 Dose Response Study of Aerobic Exercise in Older Adults Status COMPLETED Phase EARLY_PHASE1
NCT01128361 Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD) Status COMPLETED Phase NA
NCT01127633 Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT01126099 Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease Status COMPLETED Phase NA
NCT01125631 Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01120002 Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease Status UNKNOWN Phase PHASE2
NCT01119638 Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone Status COMPLETED Phase PHASE4
NCT01117818 Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease Status COMPLETED Phase PHASE2